Back to ALL Research Publications
Research Category: Pre-Clinical Applications, Detection of Bacterial Burden
Autofluorescence imaging device for real-time detection and tracking of pathogenic bacteria in a mouse skin wound model: preclinical feasibility studies
References
aUniversity Health Network, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
bUniversity of Toronto, Department of Medical Biophysics, Faculty of Medicine, 1 King’s College Circle, Toronto, Ontario M5S 1A8, Canada.
cUniversity Health Network, Department of Biostatistics, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
dUniversity of Toronto, Dalla Lana School of Public Health, 155 College Street, 6th Floor, Toronto, Ontario M5T 3M7, Canada.
eUniversity Health Network, Techna Institute, 124-100 College Street, Toronto, Ontario M5G 1P5, Canada.
Ready to see the difference?
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
Global
USA
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.
References
aUniversity Health Network, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
bUniversity of Toronto, Department of Medical Biophysics, Faculty of Medicine, 1 King’s College Circle, Toronto, Ontario M5S 1A8, Canada.
cUniversity Health Network, Department of Biostatistics, 610 University Avenue, Toronto, Ontario M5G 2M9, Canada.
dUniversity of Toronto, Dalla Lana School of Public Health, 155 College Street, 6th Floor, Toronto, Ontario M5T 3M7, Canada.
eUniversity Health Network, Techna Institute, 124-100 College Street, Toronto, Ontario M5G 1P5, Canada.